<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01539603</url>
  </required_header>
  <id_info>
    <org_study_id>E-1104/061-001</org_study_id>
    <nct_id>NCT01539603</nct_id>
  </id_info>
  <brief_title>Comparison of Drug Eluting Balloon and Drug Eluting Stent</brief_title>
  <acronym>DEBfirst</acronym>
  <official_title>Comparison of Drug-Eluting Balloon First and Then Bare Metal Stent With Drug-eluting Stent for Treatment of de Novo Lesions (DEB First): A Randomized Controlled Single Center Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of Drug-Eluting Balloon
      first and then bare metal stent compared with drug-eluting stent for treatment of de novo
      lesions (DEB first).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A recent trial to test premount bare metal stent on drug-eluting balloon failed to
      demonstrate non-inferiority and safety compared to drug-eluting stent alone for treatment of
      coronary artery stenosis.

      We think that inappropriate drug delivery to diseased vessel due to stent strut might affect
      the efficacy of drug-eluting balloon. Therefore, we design a clinical study with a different
      protocol, that is, drug-eluting balloon first and then bare metal stent implantation in
      comparison to drug-eluting stent.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>in-segment late loss</measure>
    <time_frame>9 month</time_frame>
    <description>angiographic in-segment late loss measure by QCA program</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>stent thrombosis</measure>
    <time_frame>9 month</time_frame>
    <description>any stent thrombosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>angiographic and procedure success</measure>
    <time_frame>9 month</time_frame>
    <description>Angiographic success denotes that residual diameter stenosis is less than 10% without complication such as coronarhy dissection or thrombosis.
Procedural success means that adequate DEB+BMS or DES delivery to the target lesion without geographic miss.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>9 month</time_frame>
    <description>death, MI and TVF</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">180</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Stable Angina</condition>
  <condition>Unstable Angina</condition>
  <condition>NSTEMI</condition>
  <arm_group>
    <arm_group_label>DEB-BMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug eluting balloon + Bare metal stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug eluting stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>conventional PCI with drug eluting stent drug eluting stent (Zotarolimus-eluting stent)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drug eluting balloon + Bare metal stent</intervention_name>
    <description>PCI using Sequent Please and then Coroflex Blue</description>
    <arm_group_label>DEB-BMS</arm_group_label>
    <other_name>Sequent Please (B.Braun, drug eluting balloon)</other_name>
    <other_name>Coroflex Blue (B.Braun, bare metal stent)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>drug eluting stent (Zotarolimus-eluting stent)</intervention_name>
    <description>conventional PCI using Endeavor Integrity</description>
    <arm_group_label>Drug eluting stent</arm_group_label>
    <other_name>Endeavor integrity</other_name>
    <other_name>Zotarolimus-eluting stent</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  De novo lesion

          -  2.5mm =&lt; Reference diameter =&lt; 4mm

          -  Lesion length =&lt; 28mm

          -  Type A, B1/B2 lesion

        Exclusion Criteria:

          -  ST-segment elevation MI

          -  Reference diameter &lt; 2.5mm or &gt; 4mm

          -  Bifurcation lesion

          -  Type C lesion

          -  history of AMI or stroke within 1 year F. chronic renal disease (Cr &gt; 2mg/dL)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In-Ho Chae, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National Universtiy Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 21, 2012</study_first_submitted>
  <study_first_submitted_qc>February 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2012</study_first_posted>
  <last_update_submitted>June 11, 2015</last_update_submitted>
  <last_update_submitted_qc>June 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Chang-Hwan Yoon</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <keyword>drug eluting balloon</keyword>
  <keyword>bare metal stent</keyword>
  <keyword>drug eluting stent</keyword>
  <keyword>coronary artery disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sirolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

